1Fearon W F,Fearon D T. Inflammation and cardiovascular disease:role of the intedeukin-1 receptor antagonist[J].Circulation,2008,(20):2577-2579.
2Schmieder R E,Hilgers K F,Schlaich M P,et a1. Renin-angiotensin system and cardiovascular risk[J].The Lancet,2007,(9568):1208-1219.
3Gurantz D,Cowling R T,Varki N. IL-1 beta and TNF-alpha upregulate angiotensinⅡ type 1 (AT1) receptors on cardiac fibroblasts and are associated with increased AT1 density in the post-MI heart[J].Journal of Molecular and Cellular Cardiology,2005,(03):505-515.doi:10.1016/j.yjmcc.2004.12.015.
4Takasaki G. Similarity of endothelin to snake venom toxin[J].Nature,1988,(6188):303.
7Han Y,Runge M S,Brasier A R. AngiotensinⅡ induces interleukin–6 transcription in vascular smoothmuscle cells through pleiotropic activation of nuclear factor-kappa B transcript -ion factors[J].Circulation Research,1999,(06):695-703.
8Toth P P. Epicardial steatosis,insulin resistance,and coronary artery disease[J].Heart Fail Clin,2012,(04):671-678.
9Carvalheira J B,Calegariv C,Zecchin H G,et a1. The cross talk between angiotensin and insulin differentially affects phosphatidynnositol 3-kinase and mitogen-activated protein kinase-mediated signaling in rat heart:implications for insulin resistance[J].Endocrinology,2003,(12):5604-5614.
2PARHOFER K G, MUNZEL F, KREKLER M. Effect of the angiotensin receptor blocker irbesartan on metabolic parameters in clinical practice: the DOIT prospective observational study [J]. Cardiovasc Diabetol, 2007,6:36-36.
3GERSTEIN H C, YUSUF S, BOSCH J. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial [J]. Lancet, 2006, 368:1096-1105.
4TKAC I, SALAGOVIC J, KOZAROVA M, et al. Interaction between angiotensin-converting enzyme genotype and glyeaemic control influences lipoprotein levels in type 2 diabetes mellitus [J]. Wien Klin Wochensehr, 2003,115 : 36 - 40.
5CARVALHEIRA J B, CALEGARI V C, ZECCHIN H G, et al. The cross talk between angiotensin and insulin differentially affects phosphatidylinositol 3-kinaseand mitogen-activated protein kinase-mediated signaling in rat heart: implications for insulin resistance[J]. Endocrinology, 2003,144 : 5604-5614.
6COLUSSI G, CATENA C, LAPENNA R, et al. Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients[J]. Diabetes Care, 2007,30 : 2349-2354.
7Liuzzo G, Baisucci LM, Gallore JR, et al. En-hancde inflammatory response in patients with prein-farction unstable angina[J]. J Am Coll Cardiol, 1999,34 : 1696 - 1703
8Diet F,Pratt RE, Berry G J, et al. Increased accumulation of tissue ACE in hum an atheroscleotic coronary artery disease[J]. Circulation, 1996,94:2756 - 2767
9H an Y,Rtmge MS,Brasier AR. Augiotensin Ⅱ induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-kappa B transcription factors[J]. Circulation, 1997,95:2966 - 2967
10He in rich PC,Castell JV,Andus T. In te rleuk in - 6 and the acute phase response[J]. Biochem J,2005,265:621 - 636
1Qin Zhongsheng, Guo Qianyun, Chun Lin, et al.In patients with unstable angina pectoris, Ang II, hs-CRP and MMP-9 correlation between[J]. Chinese Family Medicine, 2012, 10(2): 179-180.
2Toth P P.Epicardial steatosis, insulin resistance, and coronary artery disease[J].Herat Fail Clin, 2012, 8(4) : 671-678.
